ErbB2/Her2 antibody
Quick Overview for ErbB2/Her2 antibody (ABIN920575)
Target
See all ErbB2/Her2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Characteristics
- Tumour marker
-
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
Isotype
- IgG1
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Storage
- 4 °C/-20 °C
-
-
-
Expression of neu/c-erbB-2 in human brain tumors." in: Human pathology, Vol. 25, Issue 8, pp. 772-80, (1994) (PubMed).
: "Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry." in: Human pathology, Vol. 23, Issue 10, pp. 1141-50, (1992) (PubMed).
: "The subcellular localization of the neu protein in human normal and neoplastic cells." in: International journal of cancer. Journal international du cancer, Vol. 44, Issue 6, pp. 969-74, (1990) (PubMed).
: "Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies." in: Oncogene, Vol. 5, Issue 4, pp. 497-503, (1990) (PubMed).
: "The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues." in: Histopathology, Vol. 15, Issue 4, pp. 351-62, (1989) (PubMed).
: "Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer." in: The New England journal of medicine, Vol. 319, Issue 19, pp. 1239-45, (1988) (PubMed).
: "
-
Expression of neu/c-erbB-2 in human brain tumors." in: Human pathology, Vol. 25, Issue 8, pp. 772-80, (1994) (PubMed).
-
- ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))
-
Alternative Name
- Neu-Oncogen / C-Erb B2
-
Pathways
- RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Skeletal Muscle Fiber Development
Target
-